Presence of an N-terminal polyhistidine tag facilitates stable expression of an otherwise unstable n-terminal domain of mouse tissue inhibitor of metalloproteinase-1 in Escherichia coli

Protein Expression and Purification

Volumn 13, Issue 1, 1998, Pages 67-72

  Rajan, Shyamala S ^a,c   Lackland, Henry ^b   Stein, Stanley ^b   Denhardt, David T ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE BOND; HUMAN FIBROBLAST COLLAGENASE; METALLOPROTEINASE; MOUSE; TISSUE; TRUNCATED PROTEIN;

ESCHERICHIA COLI;

EID: 0032103808     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1998.0883     Document Type: Article

References (14)

1. Birkedal-Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., Engler J. A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. and Med. 4:1993;197-250.
2. Denhardt D. T., Feng B., Edwards D. R., Cocuzzi E. T., Malyankar U. M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacol. Ther. 59:1993;329-341.
3. Greene J., Wang M., Liu Y-.E., Raymond L. A., Rosen C., Shi Y. E. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271:1996;30375-30380.
4. Nilsson J., Ståhl S., Lundeberg J., Uhlén M., Nygren P-Å. Affinity fusion strategies for detection, purification and immobilization of recombinant proteins. Protein Express. Purif. 11:1997;1-16.
5. Cocuzzi E. T., Walther S. E., Rajan S., Denhardt D. T. Expression and purification of mouse TIMP-1 fromE. coli. FEBS Lett. 307:1992;375-378.
6. Rajan, S. S, 1997, Purification and Characterization of the N-Terminal Active Domain of the Mouse Tissue Inhibitor of Metalloproteinases-1 Expressed inEscherichia coli, Rutgers University, New Brunswick, NJ.
7. Walther S. E., Denhardt D. T. Directed mutagenesis reveals that two histidines in tissue inhibitor of metalloproteinase-1 are each essential for suppression of cell migration, invasion and tumorigenicity. Cell Growth Differ. 7:1996;1579-1588.
8. Schein C. H. Solubility as a function of protein structure and solvent components. Bio/Technology. 8:1990;308-317.
9. Negro A., Onisto M., Masiero L., Garbisa S. Synthesis and refolding of human TIMP-2 fromE. coli, FEBS Lett. 360:1995;52-56.
10. Howard E. W., Bullen E. C., Banda M. J. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J. Biol. Chem. 266:1991;13070-13075.
11. Rajan S. S., Denhardt D. T., Lackland H., Ludescher R. D. L. Analysis of the conformational stability of the active domain of recombinant mouse TIMP-1 by intrinsic fluorescence. Biochem. Biophys. Res. Commun. 242:1998;303-309.
12. Huang W., Suzuki K., Nagase H., Arumugam S., VanDoren S. R., Brew K. Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield inE. coli. FEBS Lett. 384:1996;155-161.
13. Stetler-Stevenson W. G., Liotta L. A., Kleiner D. E. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1993;1434-1441.
14. Khalkhali-Ellis Z. An improved SDS-polyacrylamide gel electrophoresis for resolution of peptides in the range of 3.5-200 kDa. Prep. Biochem. 25:1995;1-9.